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A total of 28 male BALB/c mice (average weight 20.7±1.6g) were divided into 4 treatment groups and fed a commercial diet
(A), a commercial diet + induced colitis by dextran sodium sulfate (DSS) (B), Inonotus obliquus (IO) administration (C), and IO
administration + induced colitis by DSS (D). IO treatment (C, D) decreased the expression of tumor necrosis factor (TNF)-α and
signal transducers and activators of transcription (STAT)1 compared to those of the colitis induced group (B). The expressions
of IL-4 and STAT6 were decreased in group D compared to the colitis induced group (B). The serum immunoglobulin (Ig)E
level decreased in IO treatment groups (C, D) compared to no IO treatment groups (A and B) although there was no signiﬁcant
diﬀerence between the IO treatment groups. Extract from IO itself had a weak cytotoxic eﬀect on murine macrophage cell line
(RAW264.7 cells). Extract from IO inhibited lipopolysaccharide- (LPS-) induced, TNF-α, STAT1, pSTAT1, STAT6, and pSTAT6
production in RAW264.7 cells.
1.Introduction
Inonotus obliquus (IO) is a mushroom habiting as a para-
sitism on birches in the cold latitudes of Europe and Asia. In
Russia, the black, shapeless overgrowth of the birch is usually
called Chaga and has been used for medicinal preparations
[1]. IO contains polyphenolic compounds, triterpenoids,
and steroids, such as lanosterol, inotodiol, trametenolic
acids, and ergosterol peroxides, and these compounds have
shown various biological activities [2]. Since the sixteenth
century, “Chaga” has been used as a traditional remedy
without toxicity in Russia [2] and it does not show any side
eﬀects in treatment of cancers and digestive system diseases
[3–6]. In the last decade, several studies have reported bio-
logicalactivitiesofIOsuchasanticancer,antioxidation, anti-
inﬂammatory, and enhancement of immunity. However,
there is still a relatively poor understanding of the biological
eﬀect of IO on inﬂammatory bowel disease (IBD), in spite of
its increasing studies. IBDs are idiopathic chronic, relapsing
intestinal disorders of complex pathogenesis, which are
represented mainly by Crohn’s disease (CD) and ulcerative
colitis (UC) [7]. Patients with IBD suﬀer from abdominal
pain and cramps, weight loss, diarrhea, disrupted digestion,
rectal bleeding, and a substantial burden on everyday life [8].
InAsiancountries,manyspeciesofmushroomsincludingIO
are approved adjuvants for cancer or inﬂammation therapy.
Thus, the purpose of this study was to determine the anti-
inﬂammatory eﬀect of IO in mouse model of colitis induced
by DDS and RAW 264.7 cells.
2.MaterialsandMethods
2.1. Materials. D S Sa n dL P Sw e r ep u r c h a s e df r o mS i g m a
(St, Louis, MO, USA). Monoclonal antibodies and cytokines
were purchased from ID Labs Inc. (Ontario, Canada).
IgA-related antibodies purchased from Zymed Laborato-
ries Inc. (Sanfrancisco, CA, USA). IgE related antibodies
purchased from Biosource International (Comarillo, CA,
USA). Dulbecco’s Modiﬁed Eagle’s medium (DMEM) and
3-(4,5 dimethythiazol2-yl)-2,5-diphenytetrazoleum (MTT)
wereobtainedfromWakoChemicalCo.(Tokyo,Japan).Fetal
bovine serum (FBS) and antibiotics were purchased from
Gibco-BRL (Gaithersburg, MD, USA).2 Journal of Biomedicine and Biotechnology
Table 1: Changes of body weight, organs weight, and intestine
length of mice.
Body weight (g) Organs weight (g) and length (cm)
Initiate Final Liver Spleen Intestine
A 21.0 ± 1.0 21.0 ± 6.4 1.50 ± 0.2a 0.05 ± 0.0 41.28 ± 1.5a
B 21.1 ± 0.8 20.8 ± 5.6 1.69 ± 0.2b 0.05 ± 0.0 38.80 ± 1.8b
C 20.6 ± 0.9 21.1 ± 2.7 1.96 ± 0.1d 0.11 ± 0.0 39.10 ± 1.6b
D 20.0 ± 2.4 20.8 ± 3.6 1.86 ± 0.1c 0.11 ± 0.0 37.37 ± 3.8b
(A) fed commercial diet, (B) fed commercial diet + induced colitis by DSS,
(C) administrated IO, and (D) administrated IO + induced colitis by DSS.
(n = 7f o re a c hg r o u p ) .a,b,c,dMeans with diﬀerent superscript in the same
row signiﬁcantly diﬀer at P<. 05.
2.2. The Preparation of IO. The IO was ground to a ﬁne
powder with a grinder. The powder was extracted with water
for 3 hours at 3 times. The residue was extracted at room
temperature and ﬁltered again. The extract was dried by
a rotary evaporator under vacuum at 40◦Ca n ds t o r e da t
−20◦Cuntiluse.IOextractsweredissolvedinwaterandused
for the animal experiments.
2.3. Animal Treatment. A total 28 Male BALB/c mice
(average weighing 20.7 ± 1.6g) were obtained from the
Orient Bio (Seongnam, Korea). Animals were acclimatized
under controlled conditions for 1 week before experimental
feeding, and animals were housed in individual cages in
a windowless room on a 12-h light/dark cycle, under a
protocol approved by the Institutional Animal Care and Use
Committee of the KonKuk University. Diet and sterilized
water were provided ad libitum throughout the experiment.
After 1 week adaptation, 28 animals were randomly divided
into 4 groups. A group was fed commercial diet, and B
group was fed commercial diet with colitis induced by DSS.
C group was administrated IO (20mg/kg), and D group
was administrated IO (20mg/kg) with colitis induced by
DSS. After 5 days of DSS administration, the mice resumed
drinking plain water, and mice were administered oral doses
of IO (20mg/kg) for 3 weeks.
2.4. Induction of Colitis. Colitis was induced by DSS admin-
istration as previously described by Cooper et al. [9]. Brieﬂy,
acute colitis was induced by feeding the mice with a 5%
aqueous solution of DSS over 5 days. The amount of
consumed DSS was approximately 40mg/day/mouse. After 5
days of DSS administration, the mice were treated with plain
water for 4 weeks.
2.5. Enzyme-Linked Immunosorbent Assay of Mice Antibodies.
Antibodies IgE and IgA were measured by using sandwich
ELISA methods, as reported previously by Lim et al. [10].
2.6. RAW 264.7 Cell Line and Sample Treatment. The RAW
264.7 cell was obtained from the Korea Cell bank (Seoul,
South Korea). The cells were cultured and maintained
DMEM containing 10% heat-inactivated FBS, penicillin
streptomycin (100units/mL) in a humidiﬁed atmosphere of
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Figure 1: Changes of IgA and IgE production in serum of mice. (A)
fed commercial diet, (B) fed commercial diet + induced colitis by
DSS, (C) administrated IO, and (D) administrated IO + induced
colitis by DSS (n = 7 for each group).
5% CO2 at 37◦C. The IO extract was dissolved in phosphate
buﬀered saline (PBS) and applied to the cell cultures at ﬁnal
concentrations of 0, 1, 3, 6, 9 and 12mg/mL alone or with
1μg/mL of LPS for a day.
2.7. Assessment of Cell Viability. Cytotoxicity studies were
performed in 96-well plates. RAW 264.7 cells were mechan-
ically scraped, plated at 2 × 105/well in 96-well plates
containing 100μL of DMEM with 10% heat-inactivated
FBS and incubated overnight. After overnight incubation,
the cells were washed once before adding 50μLo fF B S -
free medium containing 5mg/mL of MTT. After 4 hours
of incubation at 37◦C, the medium was discarded and the
formazan blue that formed in the cells was dissolved in
100μl of dimethyl sulfoxide (DMSO). The optical density
was measured at 540nm. The IO extract was dissolved in
phosphate buﬀered saline (PBS) and applied to the cell
cultures at ﬁnal concentrations of 0, 3, 6, 9, and 12mg/mL
a l o n eo rw i t h1μg/mL of LPS for a day.
2.8. Western Blot Analysis. Cellular proteins were extracted
from the mice with DSS-induced colitis. The cells were
collected by centrifugation and washed once with PBS.
The washed cell pellets were suspended in an extraction
lysis buﬀer (Pierce) and incubated for 10 minutes at 4◦C.
The cell debris was removed by microcentrifugation, which
was followed by quick freezing of the supernatants. TheJournal of Biomedicine and Biotechnology 3
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Figure 2: Changes of expression of cytokines in spleen of mice. (A)
fed commercial diet, (B) Fed commercial diet + induced colitis by
DSS, (C) administrated IO, and (D) administrated IO + induced
colitis by DSS (n = 7 for each group).
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Figure 3: Changes of the cell viability in RAW264.7 cell by MTT.
Control = 0LPS, LPS = 1μg LPS, LPS + 3 = 3mg LPS, LPS + 6 =
6mg LPS, LPS + 9 = 9mg LPS, LPS + 12 = 12mg LPS.
protein concentration was determined by using the Bio-
Rad protein assay reagent according to the manufacturer’s
instructions. A ﬁxed amount (50μg) of cellular protein
from the treated and untreated cell extracts was separated
using SDS-polyacrylamide gel electrophoresis and was elec-
troblottedontoanitrocellulosemembrane.Theimmunoblot
was incubated overnight with a blocking solution, fol-
lowed by incubation with dilution of polyclonal antibod-
ies against TNF-α, interleukin (IL)-4, interferon (IFN)-
γ, STAT1, and STAT6. The blots were washed twice with
Tween20/Tris-buﬀered saline (TTBS) and incubated with
diluted solutions of horseradish peroxidase-conjugated goat
antirabbit IgG secondary antibody. The blots were washed
thrice with TTBS and then developed under enhanced
chemiluminescence.
2.9. RNA Isolation and RT-PCR. To determine the expres-
sions of TNF-α mRNAs, RT-PCR was performed. Total RNA
was isolated from DSS-induced mice cells using RNAzol
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Figure 4: Changes of LPS-induced TNF-α mRNA and protein
expression in RAW 264.7 cells. (A) 0 LPS, (B) 1μgL P S ,( C )3m g
LPS, (D) 6mg LPS, (E) 9mg LPS, (F) 12mg LPS.
B( T E L - T E S T ,F r i e n d s w o o d ,T X ,U S A ) .T w om i c r o g r a m s
of RNA, Master mix (10μLo f5 xQ I A G E NO n e - S t e pR T -
PCR Buﬀer, 2μL dNTP Mix (containing 10mM of each
dNTP), 10μL of 5x Q-Solution, Primer A, Primer B, 2μL
QIAEN One-Step RT-PCR Enzyme Mix, RNase inhibitor),
and Template RNA were added to the reaction mixture.
And the ﬁnal volume was brought up to RNase-free water.
Mix the master mix thoroughly, and dispense appropriate
volumes into PCR tubes. After initial denaturation for 2
minutes at 95◦C, 30 ampliﬁcation cycles were performed for
TNF-α. PCR primers used in this study are listed below and
werepurchasedfromBioneer(Seoul,Korea):TNF-αforward
strand 5 -AANGTTCCCAANATGGCCTCCCTCTCATC -
3 ,reversestrand5 -GGAGGTTGACTTTCTCCTGGTATG-
AGA-3 ; β-actin forward strand 5 -TACAGGCTTGTCACT-
CGAANTT-3 , reverse strand 5 -CCTAGAANGCATTTG-
CGGTGCACGATG-3 . After ampliﬁcation, portions of the
PCR reactions were electrophoreses on 2% agarose gel and
visualized by ethidium bromide staining and UV irradiation.
2.10. Statistical Analysis. The data are presented as means
± SD. The diﬀerences between the means of the individ-
ual groups were assessed by one-way analysis of variance
(ANOVA) with Duncan’s multiple-range tests (Duncan,
D.B., 1955).
3. Results and Discussion
Body weight is shown in Table 1.B o d yw e i g h tw a sn o t
signiﬁcantly diﬀerent among the treatment groups. Liver
weight was signiﬁcantly lower in the DSS + IO (D) group
than that of other groups; however, spleen weight showed
no signiﬁcant diﬀerence among the treatment groups. The
intestine length of the commercial diet mice group (A) was
signiﬁcantly shorter than that of other treatment groups.
The IgE and IgA are shown in Figure 1.S e r u mI g El e v e l
decreased in the IO (C) and IO + colitis induced (D) groups
compared to the commercial diet (A) and DSS (B) groups;
however, there was no signiﬁcant diﬀerence between the IO
(C) and IO + DSS (D) groups. The expression of cytokine4 Journal of Biomedicine and Biotechnology
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Figure 5: Concentration-dependent eﬀects of IO on LPS-induced
STAT1, pSTAT1, STAT6, and pSTAT6 proteins expression in RAW
264.7 cells. (A) 0LPS, (B) 1μg LPS, (C) 0.5mg LPS, (D) 1mg LPS,
(E) 2.5mg LPS, and (F) 5mg LPS.
is shown in Figure 2. The expressions of TNF-α,I F N - γ,
and STAT1 proteins in the spleen were lower in the IO +
DSS (D) than the DSS (B) group. Similarly, the expression
of IL-4 and STAT6 decreased more in the DSS + IO (D)
than the DSS (B) group. The cell viability is shown in
Figure 3. The cell viability increased in a dose-dependent
manner in RAW264.7 cells. TNF-α, STAT1 and pSTAT1 also
increased in a dose-dependent manner in RAW264.7 cells
(Figures 4 and 5). The present study is in agreement with
Kim et al. [2]a n dY o u ne ta l .[ 11] who reported that body
weight loss was not detected by the administration of the
IO extract in mice. It is indicate that administrated IO even
in colitis induced by DSS may not inﬂuence body weight
in this study. TNF-α is not only a major inﬂammatory
cytokine and a powerful anticancer cytokine [12], but TNF-
α also induces a proinﬂammatory response [12], and TNF-
α concentrations were elevated in sera of children with
active ulcerative colitis (UC) and colonic crohn’s disease
(CD) and in stools of children with both types of IBD [13].
Increased production of IL-1, TNF-α, and IL-6 is observed
even in microscopically normal CD mucosa, and cytokine
proﬁles change during clinical evolution [14]. Thus, TNF-
α has been the target of clinical investigations aimed at
blocking its activity as a novel form of therapy for CD [14].
Park et al. [15] showed that the inhibitory eﬀects of IO
on LPS-induced TNF-α secretion occurred through TNF-
α mRNA expression and its measured accumulation. They
suggested that this action might also represent a crucial step
in the anti-inﬂammatory action of IO. Our data also shows
that IO (C, D) administration suppressed the expression
of TNF-α in animal models and cells. Thus, we assume
that IO administration could mitigate colitis in the mice
model, which induced colitis by DSS. However, Reinecker
et al. [16]r e p o r t e dt h a tp r o d u c t i o no fT N F - α is greater in
cultures of CD than UC mucosal mononuclear cells. East
and Isacke [17] reported that IFN-γ is a proinﬂammatory
cytokine that activates macrophages during inﬂammation,
while IL-4 is associated with the resolution of inﬂammation.
Liu et al. [18] also reported that the production of IFN-γ
dramatically increased; whereas IL-4 decreased in rats with
colitis compared to the healthy rat. They suggested that
mushroom polysaccharide decreased the production of IFN-
γ and increased the production of IL-4 by macrophages and
restored the condition in colitis similar to the control in vivo
[18]. However, Desreumaux et al. [19] suggested that the
elevation of IL-4 mRNA levels had distinct patterns in acute
versus chronic inﬂammation [19]. Schreiber et al. [20] also
reported that the downregulatory eﬀect of IL-4 on activated
circulating mononuclear cells is attenuated in IBD. Our data
also shows that the extract of IO suppressed the expression
of IL-4 in mice. It indicating that IO administration does not
promote IL-4. And Fiocchi [14] reported that production of
IL-4 by both CD and UC mucosal immune cell cultures has
been reported as decreased; whereas elevated IL-4 mRNA
in UC, but not CD, mucosal biopsy specimens was found
in another study. Thus, we assume that the expression of
IL-4 in IBD may not be a consistent pattern. The reason
for this diﬀerence is not fully understood, but distinct
immune regulatory mechanisms, genetically conditioned
diﬀerences of mice models, or the degree of severity of the
disease may be inﬂuences. Kim et al. [2] show that puriﬁed
endopolysaccharides extracted from IO were stronger than
crude endopolysaccharides in immunostimulating activity.
Therefore, the purity of mushroom extracts or mushroom
species could also be an inﬂuence on cytokine expression
patterns. Wasser [5] reported that mushroom polysaccha-
rides are known to stimulate natural killer cells, T-cells, B-
cells,andmacrophage-dependentimmunesystemresponses.
They suggested that mushroom polysaccharides do not
attack cancer cells directly but produce their antitumor
eﬀects by activating diﬀerent immune responses in the host.
Thus, we assume that IO administration may be inﬂuenced
indirectly against inﬂammation in the mice model. IO has
been used as a folk medicine, shown throughout many
reports published on anticancer and anti-inﬂammatory
activities [21, 22]. Park et al. [15] reported that IO is a potent
inhibitor of LPS induced NO, PGE2,a n dT N F - α production,
and that this inhibition is caused by preventing nuclear
factor (NF)-κB activation in RAW 264.7 macrophages.
Kim et al. [23] also reported that anti-inﬂammatory of
IO may be due to the inhibition of inducible NO syn-
thase (iNOS) and cyclooxygenase-2 (COX-2) expression
via the downregulation of NF-κB binding activity. More-
over, numerous studies have demonstrated that polysac-
charides extracted from mushroom exhibited beneﬁcial
therapeutic properties, including immunostimulation, anti-
infection, antitumor, wound-healing, and other therapeutic
aspects.
The possible explanation for these beneﬁcial eﬀects is
that the mushrooms including IO administration may be
a pathway associated with inﬂammatory cytokines such
as TNF-α,I F N - γ, and IL-4 secretion. In conclusion, our
experimental ﬁnding suggests the therapeutic use of IO
extract to ameliorate IBD.
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